Tsumura & Co. | Mutual Funds
Mutual Funds that own Tsumura & Co.
Baillie Gifford Overseas Growth Fund - Japanese Fund
1,584,800
2.06%
9,900
1.59%
04/30/2018
Invesco Funds - Japanese Equity Advantage Fd.
1,311,300
1.71%
-396,700
3.75%
03/29/2018
Government Pension Fund - Global (The)
1,210,500
1.58%
178,700
0.01%
12/31/2017
Nomura Asset TOPIX ETF Fund (1306)
1,128,900
1.47%
17,900
0.05%
07/31/2018
Vanguard Total International Stock Index Fund
945,823
1.23%
0
0.01%
07/31/2018
JPMorgan Funds - Japan Equity Fund
887,100
1.15%
141,700
0.69%
06/30/2018
Stichting Pensioenfonds ABP (Global Equity Portfolio)
823,057
1.07%
231,616
0.01%
03/31/2018
Templeton Global Smaller Companies Fund
653,600
0.85%
88,500
1.69%
03/31/2018
Templeton Institutional Funds - Foreign Smaller Company
588,600
0.77%
118,400
2.06%
03/31/2018
Daiwa Asset TOPIX Listed ETF (1305)
554,100
0.72%
14,400
0.06%
07/31/2018
| Address |
2-17-11 Akasaka
Tokyo Tokyo 107
Japan
|
|
Employees
|
- |
| Website |
http://www.tsumura.co.jp |
| Updated |
07/08/2019 |
| Tsumura & Co. engages in the manufacture and sale of pharmaceutical products. It manufactures and sells Kampo medicine, a traditional form of medicine in Japan. The company is also involved in the procurement, sorting, production, processing, and storage of botanical raw materials; production and sale of Kampo extract intermediates; and provision of logistics, storage, distribution, and materials handling services. |
